
Anthropic files to go public in one of the most hotly anticipated IPOs of all-time, but it's not without controversy as the Claude-maker warn of an 'existential threat to humanity.' Elsewhere, Novartis narrowly misses net sales estimates but ups its guidance thanks to strong demand for its key cancer and multiple sclerosis drugs. And HSBC shares are under pressure despite a sharp jump in quarterly profit, as a slowdown in its wealth management arm disappoints investors.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Nvidia revenue doubles as board rules out Huang return

Nvidia board rules out Huang return

Huang reportedly weighs up Nvidia return

Huang quits Nvidia, investors weigh what’s next
Free AI-powered recaps of Squawk Box Europe Express and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.